🔍

Decipher Labs Ltd (524752)

📊 BSE: 524752 🏢 Pharmaceuticals 📢 Latest filing: 14 Aug 2026

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Decipher Labs' revenue was ₹2.4 Cr (-17.3% year on year, -32.9% on the previous quarter), and net profit ₹-2.2 Cr (a smaller loss than a year earlier); the operating margin was -89.2%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹2.4	-17.3%	-32.9%
Operating profit	₹-2.2	loss narrowed	to loss
Net profit	₹-2.2	loss narrowed	loss widened
EPS (₹)	-2.16	loss narrowed	loss widened
Operating margin	-89.2%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Decipher Labs: Statutory Auditor Ramanatham & Rao to Retire at 40th AGM on Tenure Expiry

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 14 Aug 2026, 06:21 PM

Decipher Labs Limited announced the retirement of its statutory auditor, M/s. Ramanatham & Rao, Chartered Accountants (FRN: 002934S). The retirement takes effect upon the conclusion of the 40th Annual General Meeting for FY 2025-26, scheduled on or before September 30, 2026. The change is a mandatory procedural rotation upon completing the maximum permissible tenure under Section 139(2) of the Companies Act, 2013. The company confirmed that the outgoing auditor has raised no concerns or objections.

Statutory auditor M/s. Ramanatham & Rao (FRN: 002934S) to retire at the 40th AGM.
40th AGM for FY 2025-26 to be held on or before September 30, 2026.
Retirement follows completion of maximum permissible tenure under Section 139(2) of Companies Act, 2013.
No disagreements or concerns were raised by the outgoing auditor.

💡 Track the upcoming AGM notice for the proposal and approval of the incoming statutory audit firm.

Decipher Labs Q1 FY27: Revenue drops 17% to ₹2.41 Cr; Quarterly Loss is 36% of Market Cap

🔴 NEGATIVE ⭐ 6/10

EARNINGS 📅 13 Aug 2026, 06:50 PM

Decipher Labs reported a weak Q1 FY27 with consolidated revenue falling 17.4% YoY to ₹2.41 Cr. The company remains deeply in the red with a consolidated net loss of ₹2.19 Cr, which represents a significant 36.5% of its current ₹6 Cr market capitalization. Revenue is now almost entirely dependent on Consultancy Services (₹2.41 Cr), as the Pharmaceutical segment revenue collapsed to a negligible ₹0.40 Lakhs. High fixed costs remain a critical issue, with employee benefit expenses of ₹2.76 Cr exceeding the total revenue generated during the quarter.

Consolidated revenue from operations declined to ₹2.41 Cr from ₹2.92 Cr in the same quarter last year.
Net loss for the quarter stood at ₹2.19 Cr, narrowing from a loss of ₹3.43 Cr in Q1 FY26.
Employee benefit expenses reached ₹2.76 Cr, accounting for 114.5% of the total revenue from operations.
Pharmaceutical segment revenue saw a near-total wipeout, falling to just ₹0.40 Lakhs from ₹67.50 Lakhs YoY.
Consultancy services segment revenue grew slightly to ₹2.41 Cr from ₹2.25 Cr in the year-ago period.

💡 Investors should monitor the company's cash burn rate and potential for capital infusion, as quarterly losses are extremely high relative to its market capitalization. Watch for any recovery in the pharmaceutical segment or further scaling in consultancy to cover high overheads.

Decipher Labs Reports Q1 FY27 Net Loss of ₹2.19 Cr; Appoints New Independent Director

🔴 NEGATIVE ⭐ 6/10

EARNINGS 📅 13 Aug 2026, 05:24 PM

Decipher Labs reported a consolidated net loss of ₹2.19 crore for the quarter ended June 30, 2026, which is a narrowing from the ₹3.43 crore loss in the same quarter last year. Consolidated revenue from operations declined 17.4% year-on-year to ₹2.41 crore from ₹2.92 crore. The company remains under significant financial pressure, with quarterly losses representing approximately 36.5% of its total market capitalization. Additionally, the board appointed Mr. Bhupendralal Waghray, a former government tax official, as an Independent Director for a five-year term.

Consolidated revenue for Q1 FY27 decreased to ₹2.41 crore from ₹2.92 crore in Q1 FY26.
Net loss for the quarter stood at ₹2.19 crore, compared to a loss of ₹3.43 crore in the previous year's corresponding period.
Total expenses of ₹4.70 crore for the quarter significantly exceeded total income of ₹2.51 crore.
Consultancy services segment revenue on a standalone basis fell to ₹9.41 lakh from ₹17.15 lakh YoY.
Mr. Bhupendralal Waghray appointed as Additional Director (Independent) for a 5-year term effective August 13, 2026.

💡 Investors should monitor the company's cash burn and the performance of its consultancy segment, as current quarterly losses are extremely high relative to its ₹6 crore market valuation.

Rs 2.19 Cr Net Loss in Q1; Revenue drops 17% YoY to Rs 2.41 Cr

🔴 NEGATIVE ⭐ 6/10

EARNINGS 📅 13 Aug 2026, 05:21 PM

Decipher Labs reported a consolidated net loss of Rs 2.19 Cr for the quarter ended June 30, 2026, compared to a loss of Rs 3.43 Cr in the same period last year. Revenue from operations declined 17.4% YoY to Rs 2.41 Cr from Rs 2.92 Cr. A critical concern for investors is that employee benefit expenses at Rs 2.76 Cr exceeded the total revenue from operations (114.5% of revenue). The company also appointed Mr. Bhupendralal Waghray, a former government officer, as an Independent Director for a five-year term.

Consolidated net loss of Rs 2.19 Cr for Q1 FY27, representing ~36% of the company's current market cap
Revenue from operations fell to Rs 2.41 Cr, a 17.4% decline from Rs 2.92 Cr in Q1 FY26
Employee benefit expenses stood at Rs 2.76 Cr, which is 114.5% of the total revenue from operations
Total expenses of Rs 4.70 Cr significantly outpaced total income of Rs 2.51 Cr
Appointment of Bhupendralal Waghray as Additional Director (Independent) effective August 13, 2026

💡 Investors should monitor the company's ability to rationalize its high employee costs and overheads, which currently exceed its total revenue, making the business model unsustainable in its current form.

Decipher Labs Reports Q1 Net Loss of ‣2.19 Cr; Appoints New Independent Director

🔴 NEGATIVE ⭐ 6/10

EARNINGS 📅 13 Aug 2026, 05:14 PM

Decipher Labs reported a consolidated net loss of ‣2.19 Cr for Q1 FY27, narrowing from a ‣3.43 Cr loss in the same period last year. Revenue from operations declined 17.4% YoY to ‣2.41 Cr, while total expenses of ‣4.70 Cr continued to exceed total income. The company's employee benefit expenses alone (‣2.76 Cr) were higher than its total revenue from operations. Additionally, the board appointed Mr. Bhupendralal Waghray, a former government tax official, as an Independent Director for a five-year term.

Consolidated revenue from operations fell to ‣2.41 Cr from ‣2.92 Cr in the year-ago quarter.
Net loss for the quarter stood at ‣2.19 Cr, representing a significant 36.5% of the company's current ‣6 Cr market capitalization.
Employee benefit expenses reached ‣2.76 Cr, accounting for 114.4% of the quarterly revenue from operations.
Standalone operations remain negligible with revenue of only ‣9.81 Lakhs for the quarter.
Appointment of Mr. Bhupendralal Waghray as Independent Director effective August 13, 2026.

💡 Investors should monitor the company's ability to control employee costs and scale its consultancy segment, as current operations are not generating enough revenue to cover basic fixed expenses.

Decipher Labs to consider Q1 FY27 results on August 13, 2026

🟡 NEUTRAL ⭐ 2/10

BOARD_MEETING 📅 06 Aug 2026, 05:24 PM

Decipher Labs Ltd has scheduled a board meeting for August 13, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. The company is currently in a challenging financial position, reporting a TTM net loss of Rs 4 Cr and a negative operating margin of -24.2%. With a market capitalization of only Rs 6 Cr and a significant revenue drop from Rs 22.61 Cr in FY25 to Rs 14.05 Cr in FY26, these results are critical for assessing the company's survival and recovery prospects.

Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results.
Company reported a TTM revenue of Rs 14 Cr against a market cap of Rs 6 Cr.
Operating profit margin (OPM) stands at -24.2% for the trailing twelve months.
Promoter holding remains low at 16.43% as of June 2026.
Annual revenue declined by approximately 38% from FY25 (Rs 22.61 Cr) to FY26 (Rs 14.05 Cr).

💡 Monitor the August 13 results for any signs of margin improvement or revenue stabilization, as the company has faced significant top-line contraction and persistent losses.

View All 524752 Announcements on Live Market Tracking →